• Health & Medicine

Reducing the side effects of hormone therapy for prostate cancer: the ENHANCE trial

We’re launching a £3.2 million clinical trial to help men with advanced prostate cancer by reducing the side effects of hormone therapy. We’re launching a £3.2 million clinical trial to help men with advanced prostate cancer by reducing the side effects of hormone therapy.

9 March 2026

• Science & Technology

Good vibrations: how sound waves could help detect prostate cancer

Our researchers are using sound waves to help doctors detect prostate cancer using blood tests and urine tests. Our researchers are using sound waves to help doctors detect prostate cancer using blood tests and urine tests.

26 February 2026

• Health & Medicine

Thousands more men in England offered abiraterone, one of our prostate cancer treatment breakthroughs

An estimated 7,000 more men in England with hormone-sensitive prostate cancer will now be eligible for abiraterone each year. An estimated 7,000 more men in England with hormone-sensitive prostate cancer will now be eligible for abiraterone each year.

16 January 2026

• Health & Medicine
• Policy & Insight

First steps towards a targeted prostate cancer screening programme

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

28 November 2025

• Health & Medicine

Overdiagnosis: when finding cancer can do more harm than good

With new cancer detection technology on the horizon, understanding overdiagnosis is a huge challenge. With new cancer detection technology on the horizon, understanding overdiagnosis is a huge challenge.

18 November 2025

• Health & Medicine
• Policy & Insight

Detecting prostate cancer: why we need more research

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

14 April 2025

• For Researchers

The promise of proteomics for cancer prevention

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

10 September 2024

• Health & Medicine

New ‘take at home’ pill recommended for advanced prostate cancer

More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer. More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer.

19 July 2024

• Science & Technology

Our researchers light up prostate cancer cells to help surgeons cut them out

A fluorescent dye that sticks to cancer cells could make prostate cancer surgery more effective while reducing side effects. A fluorescent dye that sticks to cancer cells could make prostate cancer surgery more effective while reducing side effects.

11 June 2024

• Science & Technology

At-home saliva test could help diagnose prostate cancer sooner

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

1 June 2024

• Health & Medicine

Can prostate cancer screening with the PSA test help to save lives?

Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out.  Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out. 

6 April 2024